GlassScriptPhysician profile
Louis Hammerman
NPI 1194724310
$3,828.99
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $545 · 2020: $455 · 2021: $2,545 · 2022: $283.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,761.86 | 2020-2021 | |
| Amgen INC. | $619.78 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $437.60 | 2019-2021 | |
| Novo Nordisk INC | $192.59 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $188.15 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $167.59 | 2022 | |
| Lilly USA, LLC | $93.91 | 2019-2021 | |
| Allergan, INC. | $53.43 | 2019-2020 | |
| Pfizer INC. | $53.30 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.65 | 2020-2021 | |
| Biogen, INC. | $42.08 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $28.05 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $24.34 | 2020 | |
| Bausch Health US, LLC | $21.46 | 2019 | |
| Glaxosmithkline, LLC. | $15.00 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $15.00 | 2019 | |
| Eisai INC. | $14.12 | 2020 | |
| Abbott Laboratories | $13.44 | 2021 | |
| Abbvie INC. | $12.61 | 2022 | |
| Novartis Pharmaceuticals Corporation | $11.76 | 2021 | |
| Ibsa Pharma INC. | $11.27 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Hammerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.